<DOC>
	<DOC>NCT00015340</DOC>
	<brief_summary>The purpose of this study is the safety and efficacy of Buprenorphine/Naloxone in the treatment of opioid dependence. A compassionate use study.</brief_summary>
	<brief_title>Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14</brief_title>
	<detailed_description>The objective of this study is to provide follow-up compassionate use treatment and evaluate long term safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment for subjects who have completed Cooperative Study 1008 A and B.</detailed_description>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Heroin Dependence</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine, Naloxone Drug Combination</mesh_term>
	<mesh_term>Heroin</mesh_term>
	<criteria>Completion of Cooperative Study 1008 A/B Significant medical or psychiatric illness. Noncompliance with study procedures in the Cooperative Study 1008 A/B</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Opioid Dependence</keyword>
</DOC>